Medtronic (BSP:MDTC34) Accounts Payable: R$13,310 Mil (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:MDTC34 Medtronic PLC BSP:MDTC34
72 GF Score
Price R$212.73
GF Value R$247.49
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Medtronic Accounts Payable?

Medtronic BSP:MDTC34 72 Accounts Payable is R$13,310 Mil as of Apr. 2026. GuruFocus rates BSP:MDTC34 with a GF Score™ of 72/100 and a GF Value™ of R$247.49 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Medtronic's Accounts Payable for the quarter that ended in Apr. 2026 was R$13,310 Mil.

Medtronic's quarterly Accounts Payable declined from Oct. 2025 (R$13,894 Mil) to Jan. 2026 (R$13,697 Mil) and declined from Jan. 2026 (R$13,697 Mil) to Apr. 2026 (R$13,310 Mil).

Medtronic's annual Accounts Payable increased from Apr. 2024 (R$12,363 Mil) to Apr. 2025 (R$14,181 Mil) but then declined from Apr. 2025 (R$14,181 Mil) to Apr. 2026 (R$13,310 Mil).

Medtronic Accounts Payable Historical Data

* Premium members only.

The historical data trend for Medtronic's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medtronic Accounts Payable Chart

Medtronic Annual Data
Trend Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25 Apr26
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10,821.70 13,367.23 12,363.30 14,180.94 13,309.63

Medtronic Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14,180.94 14,137.33 13,894.04 13,696.88 13,309.63
BSP:MDTC34
72GF Score
Medtronic PLC BSP:MDTC34
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medtronic Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of R$13,310 Mil mean?
Medtronic (BSP:MDTC34) has a Accounts Payable of R$13,310 Mil as of Apr. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Medtronic and its competitors.
Is Medtronic's Accounts Payable too high?
Medtronic's current Accounts Payable is R$13,310 Mil. Overall, Medtronic has a GF Score™ of 72/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medtronic's Accounts Payable compare to SYK and BSX?
Medtronic's Accounts Payable of R$13,310 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Medical Devices & Instruments company?
A good Accounts Payable depends on the Medical Devices & Instruments industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Medtronic and its competitors. Medtronic's current Accounts Payable is R$13,310 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medtronic stock overvalued right now?
Based on GuruFocus' analysis, Medtronic (BSP:MDTC34) is currently considered Modestly Undervalued. The stock's GF Value™ is R$247.49, compared to a current price of R$212.73 — trading 14% below its estimated fair value. The current Accounts Payable is R$13,310 Mil. Medtronic's overall GF Score™ is 72/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Medtronic (BSP:MDTC34), the current Accounts Payable is R$13,310 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medtronic (BSP:MDTC34) Overvalued in 2026?

Based on GuruFocus' analysis, Medtronic stock appears to be undervalued. The current stock price of R$212.73 is trading 14% below its estimated GF Value™ of R$247.49. GuruFocus considers Medtronic to be Modestly Undervalued.

Key valuation signals for BSP:MDTC34:

  • Accounts Payable: R$13,310 Mil
  • GF Value™: R$247.49 vs. price of R$212.73 (14% below fair value)
  • GF Score™: 72/100 with 3 warning signs

No single metric tells the full story. See the BSP:MDTC34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medtronic Business Description

Address Parkmore Business Park West, Building Two, Galway, IRL
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
72GF Score

Get the complete analysis for BSP:MDTC34

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$212.73
Price
R$247.49
GF Value